Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: Literature review and case presentation

Liver Transplantation

Volumn 17, Issue 2, 2011, Pages 137-143

  Scouras, Nicole E ^a   Matsusaki, Takashi ^a   Boucek, Charles D ^a   Wells, Cynthia ^a   Cooper, Erik A ^a   Planinsic, Raymond M ^a   Sullivan, Erin A ^a   Bermudez, Christian A ^a   Toyoda, Yoshiya ^a   Sakai, Tetsuro ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; UNIPROST;

ADULT; BLEEDING; CARDIOPULMONARY BYPASS; CASE REPORT; COMBINED HEART LUNG LIVER TRANSPLANTATION; COMBINED LUNG LIVER TRANSPLANTATION; DRUG CONTRAINDICATION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW;

ANTIHYPERTENSIVE AGENTS; DRUG RESISTANCE; END STAGE LIVER DISEASE; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 79551477091     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22202     Document Type: Review

References (40)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB,. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861-880.
2. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH,. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006; 44: 1502-1510.
3. Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37: 401-409.
4. Ashfaq M, Chinnakotla S, Rogers L, Ausloos K, Saadeh S, Klintmalm GB, et al. The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant 2007; 7: 1258-1264.
5. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174-182.
6. Barth F, Gerber PJ, Reichen J, Dufour JF, Nicod LP,. Efficiency and safety of bosentan in Child C cirrhosis with portopulmonary hypertension and renal insufficiency. Eur J Gastroenterol Hepatol 2006; 18: 1117-1119.
7. Stähler G, von Hunnius P,. Successful treatment of portopulmonary hypertension with bosentan: case report. Eur J Clin Invest 2006; 36 (suppl 3): 62-66.
8. Makisalo H, Koivusalo A, Vakkuri A, Hockerstedt K,. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl 2004; 10: 945-950.
9. Chua R, Keogh A, Miyashita M,. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 2005; 24: 498-500. (Pubitemid 40403811)
10. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ,. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997; 63: 604-606.
11. Plotkin JS, Kuo PC, Rubin LJ, Gaine S, Howell CD, Laurin J, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998; 65: 457-459.
12. Tan HP, Markowitz JS, Montgomery RA, Merritt WT, Klein AS, Thuluvath PJ, et al. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 2001; 7: 745-749.
13. Minder S, Fischler M, Muellhaupt B, Zalunardo MP, Jenni R, Clavien PA, Speich R. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J 2004; 24: 703-707.
14. Sakai T, Planinsic RM, Mathier MA, de Vera ME, Venkataramanan R,. Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease. Transpl Int 2009; 22: 554-561.
15. Halank M, Kolditz M, Miehlke S, Schiemanck S, Schmeisser A, Hoeffken G,. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wien Med Wochenschr 2005; 155: 376-380.
16. Austin MJ, McDougall NI, Wendon JA, Sizer E, Knisely AS, Rela M, et al. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl 2008; 14: 287-291.
17. Couetil JP, Houssin DP, Soubrane O, Chevalier PG, Dousset BE, Loulmet D, et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1995; 110: 1415-1422.
18. Moreno Casado P, Alvarez Kindelán A, Algar Algar FJ, Espinosa Jiménez D, Cano García JR, Cerezo Madueño F, et al. Combined lung and liver transplantation - University Hospital Reina Sofia experience: two case reports. Transplant Proc 2008; 40: 3126-3127.
19. Corno V, Dezza MC, Lucianetti A, Codazzi D, Carrara B, Pinelli D, et al. Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. Am J Transplant 2007; 7: 2433-2438.
20. Barshes NR, DiBardino DJ, McKenzie ED, Lee TC, Stayer SA, Mallory GB, et al. Combined lung and liver transplantation: the United States experience. Transplantation 2005; 80: 1161-1167.
21. Zimmerman AA, Howard TK, Huddleston CB,. Combined lung and liver transplantation in a girl with cystic fibrosis. Can J Anaesth 1999; 46: 571-575.
22. Konstantinov IE, McNeil K, Yeung S, Fawcett J, Mullany D, Dunning J,. Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension. Heart Lung Circ 2008; 17: 154-156.
23. Wise PE, Wright JK, Chapman WC, Drinkwater DC, Slovis BS, Pierson RN, Pinson CW,. Heart-lung-liver transplant for cystic fibrosis. Transplant Proc 2001; 33: 3568-3571.
24. Grannas G, Neipp M, Hoeper MM, Gottlieb J, Lück R, Becker T, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation 2008; 85: 524-531.
25. Praseedom RK, McNeil KD, Watson CJ, Alexander GJ, Calne RY, Wallwork J, Friend PJ,. Combined transplantation of the heart, lung, and liver. Lancet 2001; 358: 812-813.
26. Bund M, Seitz W, Schäfers HJ, Ringe B, Kirchner E,. Combined lung and liver transplantation. Anesthesiologic management [in German]. Anaesthesist 1994; 43: 322-329.
27. Gandhi SK, Reyes J, Webber SA, Siewers RD, Pigula FA,. Case report of combined pediatric heart-lung-liver transplantation. Transplantation 2002; 73: 1968-1969.
28. Sakai T, Gligor S, Diulus J, McAffee R, Marsh JW, Planinsic RM,. Insertion and management of percutaneous veno-venous bypass cannula for liver transplantation: a reference for transplant anesthesiologists. Clin Transplant 2010; 24: 585-591.
29. Toyoda Y,. A minimally invasive incision for lung transplantation: antero-axillary approach. Kardiochirurgiai Torakochirurgia Polska 2007; 4: 408-410.
30. Heath D, Edwards JE,. The pathology of hypertensive pulmonary vascular disease. Circulation 1958; 18: 533-547.
31. Kotru A, Sheperd R, Nadler M, Chapman W, Huddleston C, Lowell J,. Combined lung and liver transplantation: the United States experience. Transplantation 2006; 82: 144-145.
32. Faro A, Shepherd R, Huddleston CB, Lowell J, Gandhi S, Nadler M, Sweet SC,. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis. Transplantation 2007; 83: 1435-1439.
33. Couetil JP, Soubrane O, Houssin DP, Dousset BE, Chevalier PG, Guinvarch A, et al. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997; 10: 33-39.
34. Dennis CM, McNeil KD, Dunning J, Stewart S, Friend PJ, Alexander G, et al. Heart-lung-liver transplantation. J Heart Lung Transplant 1996; 15: 536-538.
35. Chavez-Cartaya R, Drage M, Jamieson NV, Friend P, Noble-Jamieson G, Levy R, et al. Biliary complications in liver transplantation for cystic fibrosis. Transplant Proc 1999; 31: 2411-2412. (Pubitemid 29433979)
36. Pirenne J, Verleden G, Nevens F, Delcroix M, Van Raemdonck D, Meyns B, et al. Combined liver and (heart-) lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. Transplantation 2002; 73: 140-156.
37. Wallwork J, Williams R, Calne RY,. Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet 1987; 2: 182-185.
38. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, et al. Combined heart and liver transplantation: a single-center experience. Transplantation 2009; 88: 219-225.
39. Ramsay M,. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol 2010; 23: 145-150.
40. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA,. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443-450.